Company intelligence / Profile preview
TCI Gene
Taipei City, Taipei City, Taiwangenext.me ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TCI Gene is a leading Taiwanese biotech specializing in gene testing services, stem cell-based medicinal products including natural killer cells, virus detection services, personalized gene health foods/supplements, and human stem cell therapy. It operates globally with a focus on precision medicine solutions spanning preventive diagnostics to advanced therapies. The company is part of the larger TCI group which has extensive CDMO capabilities across supplements/health foods/skincare as well as medical devices through its subsidiaries[1][2][3].
- Therapeutic areas
- Infectious DiseasesOther
- Modalities
- Gene therapyCell therapyStem cell therapyPersonalized health food (nutraceuticals/functional foods)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on TCI Gene.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TCI Gene.